Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Concurrent activation of β2-adrenergic receptor and blockage of GPR55 disrupts pro-oncogenic signaling in glioma cells.

Wnorowski A, Such J, Paul RK, Wersto RP, Indig FE, Jozwiak K, Bernier M, Wainer IW.

Cell Signal. 2017 Aug;36:176-188. doi: 10.1016/j.cellsig.2017.05.006. Epub 2017 May 8.

2.

Immunosuppressive and Prometastatic Functions of Myeloid-Derived Suppressive Cells Rely upon Education from Tumor-Associated B Cells.

Bodogai M, Moritoh K, Lee-Chang C, Hollander CM, Sherman-Baust CA, Wersto RP, Araki Y, Miyoshi I, Yang L, Trinchieri G, Biragyn A.

Cancer Res. 2015 Sep 1;75(17):3456-65. doi: 10.1158/0008-5472.CAN-14-3077. Epub 2015 Jul 16.

3.

A human pluripotent stem cell surface N-glycoproteome resource reveals markers, extracellular epitopes, and drug targets.

Boheler KR, Bhattacharya S, Kropp EM, Chuppa S, Riordon DR, Bausch-Fluck D, Burridge PW, Wu JC, Wersto RP, Chan GC, Rao S, Wollscheid B, Gundry RL.

Stem Cell Reports. 2014 Jun 6;3(1):185-203. doi: 10.1016/j.stemcr.2014.05.002. eCollection 2014 Jul 8.

4.

Non-steroidal anti-inflammatory drugs decrease E2F1 expression and inhibit cell growth in ovarian cancer cells.

Valle BL, D'Souza T, Becker KG, Wood WH 3rd, Zhang Y, Wersto RP, Morin PJ.

PLoS One. 2013 Apr 24;8(4):e61836. doi: 10.1371/journal.pone.0061836. Print 2013.

5.

Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B cells expressing low levels of CD20 and CD137L.

Bodogai M, Lee Chang C, Wejksza K, Lai J, Merino M, Wersto RP, Gress RE, Chan AC, Hesdorffer C, Biragyn A.

Cancer Res. 2013 Apr 1;73(7):2127-38. doi: 10.1158/0008-5472.CAN-12-4184. Epub 2013 Jan 30.

6.

The B-MYB transcriptional network guides cell cycle progression and fate decisions to sustain self-renewal and the identity of pluripotent stem cells.

Zhan M, Riordon DR, Yan B, Tarasova YS, Bruweleit S, Tarasov KV, Li RA, Wersto RP, Boheler KR.

PLoS One. 2012;7(8):e42350. doi: 10.1371/journal.pone.0042350. Epub 2012 Aug 24.

7.

Cannabinoid receptor activation correlates with the proapoptotic action of the β2-adrenergic agonist (R,R')-4-methoxy-1-naphthylfenoterol in HepG2 hepatocarcinoma cells.

Paul RK, Ramamoorthy A, Scheers J, Wersto RP, Toll L, Jimenez L, Bernier M, Wainer IW.

J Pharmacol Exp Ther. 2012 Oct;343(1):157-66. doi: 10.1124/jpet.112.195206. Epub 2012 Jul 9.

8.

Intratumor heterogeneity and branched evolution.

Wersto RP, Koss LG.

N Engl J Med. 2012 May 31;366(22):2132; author reply 2133. doi: 10.1056/NEJMc1204069. No abstract available.

PMID:
22646643
9.

A cell surfaceome map for immunophenotyping and sorting pluripotent stem cells.

Gundry RL, Riordon DR, Tarasova Y, Chuppa S, Bhattacharya S, Juhasz O, Wiedemeier O, Milanovich S, Noto FK, Tchernyshyov I, Raginski K, Bausch-Fluck D, Tae HJ, Marshall S, Duncan SA, Wollscheid B, Wersto RP, Rao S, Van Eyk JE, Boheler KR.

Mol Cell Proteomics. 2012 Aug;11(8):303-16. doi: 10.1074/mcp.M112.018135. Epub 2012 Apr 6.

10.

Embryonic stem cell-derived cardiomyocyte heterogeneity and the isolation of immature and committed cells for cardiac remodeling and regeneration.

Boheler KR, Joodi RN, Qiao H, Juhasz O, Urick AL, Chuppa SL, Gundry RL, Wersto RP, Zhou R.

Stem Cells Int. 2011;2011:214203. doi: 10.4061/2011/214203. Epub 2011 Sep 6.

11.

Translational control of TOP2A influences doxorubicin efficacy.

Srikantan S, Abdelmohsen K, Lee EK, Tominaga K, Subaran SS, Kuwano Y, Kulshrestha R, Panchakshari R, Kim HH, Yang X, Martindale JL, Marasa BS, Kim MM, Wersto RP, Indig FE, Chowdhury D, Gorospe M.

Mol Cell Biol. 2011 Sep;31(18):3790-801. doi: 10.1128/MCB.05639-11. Epub 2011 Jul 18.

12.

Krüppel-like factor 4 (KLF4) directly regulates proliferation in thymocyte development and IL-17 expression during Th17 differentiation.

An J, Golech S, Klaewsongkram J, Zhang Y, Subedi K, Huston GE, Wood WH 3rd, Wersto RP, Becker KG, Swain SL, Weng N.

FASEB J. 2011 Oct;25(10):3634-45. doi: 10.1096/fj.11-186924. Epub 2011 Jun 17.

13.

Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4⁺ T cells to T-regulatory cells.

Olkhanud PB, Damdinsuren B, Bodogai M, Gress RE, Sen R, Wejksza K, Malchinkhuu E, Wersto RP, Biragyn A.

Cancer Res. 2011 May 15;71(10):3505-15. doi: 10.1158/0008-5472.CAN-10-4316. Epub 2011 Mar 28.

14.

Zscan4 regulates telomere elongation and genomic stability in ES cells.

Zalzman M, Falco G, Sharova LV, Nishiyama A, Thomas M, Lee SL, Stagg CA, Hoang HG, Yang HT, Indig FE, Wersto RP, Ko MS.

Nature. 2010 Apr 8;464(7290):858-63. doi: 10.1038/nature08882. Epub 2010 Mar 24.

15.

Genome-wide analysis of histone methylation reveals chromatin state-based regulation of gene transcription and function of memory CD8+ T cells.

Araki Y, Wang Z, Zang C, Wood WH 3rd, Schones D, Cui K, Roh TY, Lhotsky B, Wersto RP, Peng W, Becker KG, Zhao K, Weng NP.

Immunity. 2009 Jun 19;30(6):912-25. doi: 10.1016/j.immuni.2009.05.006. Epub 2009 Jun 11.

16.

Enhanced proliferation of monolayer cultures of embryonic stem (ES) cell-derived cardiomyocytes following acute loss of retinoblastoma.

Yamanaka S, Zahanich I, Wersto RP, Boheler KR.

PLoS One. 2008;3(12):e3896. doi: 10.1371/journal.pone.0003896. Epub 2008 Dec 10.

17.

Nontelomeric TRF2-REST interaction modulates neuronal gene silencing and fate of tumor and stem cells.

Zhang P, Pazin MJ, Schwartz CM, Becker KG, Wersto RP, Dilley CM, Mattson MP.

Curr Biol. 2008 Oct 14;18(19):1489-94. doi: 10.1016/j.cub.2008.08.048. Epub 2008 Sep 25.

18.

B-MYB is essential for normal cell cycle progression and chromosomal stability of embryonic stem cells.

Tarasov KV, Tarasova YS, Tam WL, Riordon DR, Elliott ST, Kania G, Li J, Yamanaka S, Crider DG, Testa G, Li RA, Lim B, Stewart CL, Liu Y, Van Eyk JE, Wersto RP, Wobus AM, Boheler KR.

PLoS One. 2008 Jun 25;3(6):e2478. doi: 10.1371/journal.pone.0002478.

19.

Pluripotency of embryonic stem cells.

Yamanaka S, Li J, Kania G, Elliott S, Wersto RP, Van Eyk J, Wobus AM, Boheler KR.

Cell Tissue Res. 2008 Jan;331(1):5-22. Epub 2007 Nov 16.

PMID:
18026755
20.

Mitochondrial UCP4 mediates an adaptive shift in energy metabolism and increases the resistance of neurons to metabolic and oxidative stress.

Liu D, Chan SL, de Souza-Pinto NC, Slevin JR, Wersto RP, Zhan M, Mustafa K, de Cabo R, Mattson MP.

Neuromolecular Med. 2006;8(3):389-414.

PMID:
16775390
21.

Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability.

Yuan B, Xu Y, Woo JH, Wang Y, Bae YK, Yoon DS, Wersto RP, Tully E, Wilsbach K, Gabrielson E.

Clin Cancer Res. 2006 Jan 15;12(2):405-10.

22.

Different mutation signatures in DNA polymerase eta- and MSH6-deficient mice suggest separate roles in antibody diversification.

Martomo SA, Yang WW, Wersto RP, Ohkumo T, Kondo Y, Yokoi M, Masutani C, Hanaoka F, Gearhart PJ.

Proc Natl Acad Sci U S A. 2005 Jun 14;102(24):8656-61. Epub 2005 Jun 6.

23.

Nestin expression--a property of multi-lineage progenitor cells?

Wiese C, Rolletschek A, Kania G, Blyszczuk P, Tarasov KV, Tarasova Y, Wersto RP, Boheler KR, Wobus AM.

Cell Mol Life Sci. 2004 Oct;61(19-20):2510-22. Review.

PMID:
15526158
24.

Cell cycle activation linked to neuronal cell death initiated by DNA damage.

Kruman II, Wersto RP, Cardozo-Pelaez F, Smilenov L, Chan SL, Chrest FJ, Emokpae R Jr, Gorospe M, Mattson MP.

Neuron. 2004 Feb 19;41(4):549-61.

25.

PTEN expression in PTEN-null leukaemic T cell lines leads to reduced proliferation via slowed cell cycle progression.

Seminario MC, Precht P, Wersto RP, Gorospe M, Wange RL.

Oncogene. 2003 Nov 6;22(50):8195-204.

PMID:
14603260
26.

Red cell perturbations by amyloid beta-protein.

Jayakumar R, Kusiak JW, Chrest FJ, Demehin AA, Murali J, Wersto RP, Nagababu E, Ravi L, Rifkind JM.

Biochim Biophys Acta. 2003 Jun 20;1622(1):20-8.

PMID:
12829257
27.

Microarray analysis of selected genes in neural stem and progenitor cells.

Luo Y, Cai J, Liu Y, Xue H, Chrest FJ, Wersto RP, Rao M.

J Neurochem. 2002 Dec;83(6):1481-97.

28.

Arsenic trioxide promotes histone H3 phosphoacetylation at the chromatin of CASPASE-10 in acute promyelocytic leukemia cells.

Li J, Chen P, Sinogeeva N, Gorospe M, Wersto RP, Chrest FJ, Barnes J, Liu Y.

J Biol Chem. 2002 Dec 20;277(51):49504-10. Epub 2002 Oct 17.

29.

Variable levels of chromosomal instability and mitotic spindle checkpoint defects in breast cancer.

Yoon DS, Wersto RP, Zhou W, Chrest FJ, Garrett ES, Kwon TK, Gabrielson E.

Am J Pathol. 2002 Aug;161(2):391-7.

30.

Doublet discrimination in DNA cell-cycle analysis.

Wersto RP, Chrest FJ, Leary JF, Morris C, Stetler-Stevenson MA, Gabrielson E.

Cytometry. 2001 Oct 15;46(5):296-306.

31.

Differential regulation of sphingosine-1-phosphate- and VEGF-induced endothelial cell chemotaxis. Involvement of G(ialpha2)-linked Rho kinase activity.

Liu F, Verin AD, Wang P, Day R, Wersto RP, Chrest FJ, English DK, Garcia JG.

Am J Respir Cell Mol Biol. 2001 Jun;24(6):711-9.

PMID:
11415936
33.

Lentivirus vector-mediated hematopoietic stem cell gene transfer of common gamma-chain cytokine receptor in rhesus macaques.

An DS, Kung SK, Bonifacino A, Wersto RP, Metzger ME, Agricola BA, Mao SH, Chen IS, Donahue RE.

J Virol. 2001 Apr;75(8):3547-55.

34.

Marking and gene expression by a lentivirus vector in transplanted human and nonhuman primate CD34(+) cells.

An DS, Wersto RP, Agricola BA, Metzger ME, Lu S, Amado RG, Chen IS, Donahue RE.

J Virol. 2000 Feb;74(3):1286-95.

35.

High levels of lymphoid expression of enhanced green fluorescent protein in nonhuman primates transplanted with cytokine-mobilized peripheral blood CD34(+) cells.

Donahue RE, Wersto RP, Allay JA, Agricola BA, Metzger ME, Nienhuis AW, Persons DA, Sorrentino BP.

Blood. 2000 Jan 15;95(2):445-52.

PMID:
10627448
36.

Transplantation of transduced nonhuman primate CD34+ cells using a gibbon ape leukemia virus vector: restricted expression of the gibbon ape leukemia virus receptor to a subset of CD34+ cells.

Bunnell BA, Kluge KA, Lee-Lin SQ, Byrne ER, Orlic D, Metzger ME, Agricola BA, Wersto RP, Bodine DM, Morgan RA, Donahue RE.

Gene Ther. 1999 Jan;6(1):48-56.

37.
38.

Use of the green fluorescent protein as a marker to identify and track genetically modified hematopoietic cells.

Persons DA, Allay JA, Riberdy JM, Wersto RP, Donahue RE, Sorrentino BP, Nienhuis AW.

Nat Med. 1998 Oct;4(10):1201-5. No abstract available.

PMID:
9771757
39.

Thapsigargin-induced gene expression in nonexcitable cells is dependent on calcium influx.

Rodland KD, Wersto RP, Hobson S, Kohn EC.

Mol Endocrinol. 1997 Mar;11(3):281-91.

PMID:
9058375
40.

Identification and characterization of human metabolites of CAI [5-amino-1-1(4'-chlorobenzoyl-3,5-dichlorobenzyl)-1,2,3-triazole- 4-carboxamide).

Soltis MJ, Yeh HJ, Cole KA, Whittaker N, Wersto RP, Kohn EC.

Drug Metab Dispos. 1996 Jul;24(7):799-806.

PMID:
8818579
41.
42.

Signal transduction as a therapeutic target.

Alessandro R, Spoonster J, Wersto RP, Kohn EC.

Curr Top Microbiol Immunol. 1996;213 ( Pt 3):167-88. Review. No abstract available.

PMID:
8815004
43.

Debris compensation of DNA histograms and its effect on S-phase analysis.

Wersto RP, Stetler-Stevenson M.

Cytometry. 1995 May 1;20(1):43-52.

44.

Angiogenesis: role of calcium-mediated signal transduction.

Kohn EC, Alessandro R, Spoonster J, Wersto RP, Liotta LA.

Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1307-11.

45.

Direct in vivo gene transfer and expression in malignant cells using adenovirus vectors.

Brody SL, Jaffe HA, Han SK, Wersto RP, Crystal RG.

Hum Gene Ther. 1994 Apr;5(4):437-47.

PMID:
7519451
46.

Asymmetric distribution of oncogene products at mitosis.

Czerniak B, Herz F, Wersto RP, Koss LG.

Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):4860-3.

47.

Flow cytometric DNA analysis of human solid tumors: a review of the interpretation of DNA histograms.

Wersto RP, Liblit RL, Koss LG.

Hum Pathol. 1991 Nov;22(11):1085-98. Review.

PMID:
1743692
48.

Protein expression in relation to the cell cycle of exponentially growing human prostatic epithelial cells.

Herz F, Czerniak B, Deitch D, Wersto RP, Simmons DA, Koss LG.

Cell Prolif. 1991 May;24(3):321-30.

PMID:
2039807
49.

Variability in DNA measurements in multiple tumor samples of human colonic carcinoma.

Wersto RP, Liblit RL, Deitch D, Koss LG.

Cancer. 1991 Jan 1;67(1):106-15.

PMID:
1985705
50.

Quantitation of oncogene products by computer-assisted image analysis and flow cytometry.

Czerniak B, Herz F, Wersto RP, Alster P, Puszkin E, Schwarz E, Koss LG.

J Histochem Cytochem. 1990 Apr;38(4):463-6.

PMID:
1969431

Supplemental Content

Loading ...
Support Center